Abstract
A human myelomonocytic cell line, U937, produced an interleukin-1 (IL-1) receptor antagonist protein (IRAP) which was purified and partially sequenced. A complementary DNA coding for IRAP was cloned and sequenced. The mature translation product of the cDNA has been expressed in Escherichia coli and was an active competitive inhibitor of the binding of IL-1 to the T-cell/fibroblast form of the IL-1 receptor. Recombinant IRAP specifically inhibited IL-1 bioactivity on ¤ cells and endothelial cells in vitro and was a potent inhibitor of IL-1 induced corticosterone production in vivo
Similar content being viewed by others
References
Dinarello, C. A. FASEB J. 2, 108–115 (1988).
Oppenheim, J. J., Kovacs, E. J., Matsushima, K. & Durum, S. K. Immunol. Today 7, 45–56 (1986).
Larrick, J. W. & Kundel, S. L. Pharm. Res. 5, 129–139 (1988).
Besedovsky H., del Rev, A., Sorkin, F. & Dinarello, C. A. Science 233, 652–654 (1986).
Snyder, D. S. & Unanue, E. R. J. Immun. 129, 1803–1805 (1982).
Tracey, D. E., Hardee, M. M., Richard, K. A. & Paslay, J. W. Immunopharmacology 15, 47–62 (1988).
Arend, W. P., Joslin, F. G. & Massoni, R. J. J. Immun. 134, 3868–3875 (1985).
Hannum, C. H. et al. Nature 343, 336–340 (1990).
Eisenberg, S. P. et al. Nature 343, 341–346 (1990).
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M. & MacDonald, H. R. J. Immun. 139, 1546–1549 (1987).
Roux-Lombard, P., Modoux, C. & Dayer, J-M. Cytokine 1, 45–51 (1989).
Harris, P. & Ralph P. J. Leukocyte Biol 37, 407–413 (1985).
Matsushima, K., Yodoi, J., Tagaya, Y. & Oppenheim, J. J. J Immun. 137, 3183–3188 (1986).
Gillis, S. & Mizel, S. B. Proc. natn. Acad. Sci. U.S.A. 78, 1133–1137 (1981).
Higgins, D. G. & Sharp, P. M. Gene 73, 237–244 (1988).
Caput, D. et al. Proc. natn. Acad. Sci. U.S.A. 83, 1670–1674 (1986).
Shaw, G. & Kamen, R. Cell 46, 659–667 (1986).
Olsen, M. K., Rockenbach, S. K., Curry, K. A. & Tomich, C.-S. C. J. Biotech. 9, 179–190 (1989).
Schleimer, R. P. & Rutledge, B. K. J. Immun. 136, 649–654 (1985).
Gery, I., Gershon, R. K. & Waksman, B. H. J. exp. Med. 136, 128–142 (1972).
Morrisey, P. J., Charrier, K., Alpert, A. & Bressler, L. J. Immun. 141, 1456–1463 (1988).
Ulich, T. R., del Castillo, J., Keys, M., Granger, G. A. & Ni, R.-X. J. Immun. 139, 3406–3415 (1987).
Tracey, D. E. & De Souza, E. B. Soc. Neurosci. Abst. 14, 1052 (1988).
Bomsztyk, K. et al. Proc. natn. Acad. Sci. U.S.A. 86, 8034–8038 (1989).
Chizzonite, R. et al. Proc. natn. Acad. Sci. U.S.A. 86, 8029–8033 (1989).
Benjamin, W. R. et al. J. Immun. 142, 792–799 (1989).
Ohlsson, K. et al. Cytokine 1, 131 (1989).
Mclntyre, K. W. et al. Cytokine 1, 150 (1989).
Carter, D. B. et al. Proteins: Structure, Function and Genetics 3, 121–129 (1988).
Laemmli, U. K. Nature 227, 680–685 (1970).
Sinha, N. D. Nucleic Acids Res. 12, 4539–4557 (1984).
Lehrach, H., Diamond, D., Wozney, J. M. & Boedtker, H. Biochemistry 16, 4743–4751 (1977).
Benton, W. D. & Davis, R. W. Science 196, 180–182 (1977).
Leder, P., Tiemeier, D. & Enquist, L. Science 196, 175–177 (1977).
Bosma, P. J., Van der Berg, E., Kooistra, T., Siemieniak, D. & Slightom, J. J. biol. Chem. 263, 9129–9141 (1988).
Smith, R. J., Justen, J. M. & Sam, L. M. Inflammation 12, 597–611 (1988).
Hensel, T. et al. J. Immunol. Meth. 122, 97–104 (1989).
Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. J. clin. Invest. 52, 2745–2756 (1973).
Dower, S. K. et al. J. exp. Med. 162, 501–515 (1985).
Dower, S. K. et al. Nature 324, 266–268 (1986).
Titeler, M. Receptor Pharmacology and Function (eds Williams, M., Glennon, R. A. & Timmermans, P. B.) 17–46 (Dekker, New York, 1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carter, D., Deibel , M., Dunn, C. et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344, 633–638 (1990). https://doi.org/10.1038/344633a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/344633a0
- Springer Nature Limited
This article is cited by
-
Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system
BMC Biotechnology (2023)
-
The Future of IL-1 Targeting in Kidney Disease
Drugs (2018)
-
Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis
Microbiome (2017)
-
Interleukin-1 function and role in rheumatic disease
Nature Reviews Rheumatology (2016)
-
Associations between interleukin-1 polymorphisms and susceptibility to vasculitis: a meta-analysis
Zeitschrift für Rheumatologie (2016)